A pooled analysis of two phase 3 ENHANCE trials evaluated whether the inhaled dual phosphodiesterase 3 and 4 inhibitor antifeminine reduces chronic obstructive pulmonary disease exacerbation frequency and...
A new national analysis provides clinicians with evidence on how chronic obstructive pulmonary disease affects post-discharge outcomes in adults with sickle cell disease hospitalized for acute chest...
A nationwide Belgian cohort study found that biologic therapy targeting interleukin (IL) 5 reduced moderate and severe exacerbations among adults with severe eosinophilic asthma, including those with...
Researchers in Graz, Austria, used machine learning and multiomics immune profiling to uncover a distinct chronic obstructive pulmonary disease subtype tied to emphysema severity and reduced gas exchange....
In a nationwide Danish trial of more than 130,000 adults aged 60 years and older, a single dose of the bivalent RSV prefusion F protein vaccine reduced all-cause cardiorespiratory hospitalizations by nearly...
A randomized clinical trial tested whether a digital health program delivered directly to patients could increase lung cancer screening rates among eligible adults. Conducted at two academic health systems,...
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, but it’s also highly manageable with early recognition, evidence-based treatment, and coordinated care. This guide...
In a large, randomized trial, high-flow nasal oxygen was found noninferior to noninvasive ventilation for most patient groups with acute respiratory failure, though uncertainties remain for...
A randomized trial in moderate chronic obstructive pulmonary disease demonstrated that chest mobility exercises led to greater improvements in lung function and functional capacity compared with...
